Cost Management In Cardiac Care Archives – January 1, 1998
January 1, 1998
View Issues
-
There’s a revolution in AMI care: Reteplase could save time and lives
-
Avoid Trouble: Choose Reteplase Candidates with Care
-
Reteplase is an early prognostic indicator
-
Reteplase designed for use in the field
-
Clot-busters nearly equal, GUSTO report shows
-
Reteplase achieves patency, reduces mortality
-
Profiling moves from defense to offense
-
New-generation stents show promise
-
Clopidogrel pricey, but may edge aspirin
-
Cholesterol drug may impair brain function